Skip to main content
. 2015 Apr 12;14:25. doi: 10.1186/s12944-015-0025-2

Table 1.

Association of clinical data and apoE genotype between hyperuricemia patients and control group

Clinicopathological data Control group (mean ± SD) ( n= 518) Hyperuricemia patients (mean ± SD) ( n= 474) p -value/
Age (yrs.) 46.60 ± 11.87 47.28 ± 13.44 0.401
Stature (cm) 169.94 ± 5.11 170.28 ± 5.39 0.312
Weight (kg) 77.38 ± 9.23 80.99 ± 14.19* <0.05
BMI (kg/m2) 26.79 ± 2.96 27.88 ± 4.42* <0.001
WC (cm) 93.72 ± 8.62 97.51 ± 11.57* <0.001
Hip circumferences (cm) 101.69 ± 7.15 102.81 ± 10.57* 0.045
WHR 0.92 ± 0.05 0.95 ± 0.07* <0.001
SBP (mmHg) 110.81 ± 16.34 118.28 ± 18.21* <0.001
DBP (mmHg) 95.81 ± 21.46 103.86 ± 23.38* <0.001
BUN (mg/dl) 5.23 ± 1.44 6.47 ± 3.57* <0.001
Cr (mg/dl) 77.44 ± 18.14 88.91 ± 35.23* 0.003
SUA (mmol/L) 308.51 ± 60.25 495.42 ± 83.66* <0.001
FBS (mmol/L) 5.18 ± 1.16 5.41 ± 1.80* 0.017
TG (mmol/L) 2.88 ± 1.76 2.75 ± 1.57* 0.005
TC (mmol/L) 4.19 ± 1.48 4.24 ± 1.41 0.594
HDL-C (mmol/L) 1.20 ± 0.43 1.13 ± 0.61* 0.043
LDL-C (mmol/L) 2.65 ± 0.88 2.74 ± 0.77 0.088
Genotype* N (%) N (%) χ2 value
E2/2 24 (4.6) 1 (0.2) 0.000
E2/3 61 (11.8) 44 (9.3)
E2/4 3 (0.6) 11 (2.3)
E3/3 353 (68.1) 359 (75.7)
E3/4 15 (2.9) 44 (9.3)
E4/4 62 (12.0) 15 (3.2)
Allele 0.000
E2 112 (10.8) 57 (6.0)
E3 782 (75.7) 806 (85.0)
E4 139 (13.5) 85 (9.0)

A t-test and Pearson Chi-square (χ2) test were used to analyze the data. *The mean difference was significant at the 0.05 level. Data are presented as range, mean ± standard deviation, or percentage. BMI, Body Mass Index; WC, Waist Circumference; WHR, Waist Hip Ratio; SUA, Serum Uric Acid; TG, Serum Triglyceride; TC, Serum Total Cholesterol; HDL-C, Serum High Density Lipoprotein; LDL-C, Serum Low Density Lipoprotein; FBS, Fasting Blood Sugar; BUN, Urea Nitrogen; SCR, Serum Creatinine.